**Specifications table**TableSubject areaMedicine and dentistryMore specific subject area1.Inflammatory Bowel Disease2.Reproductive HealthType of dataTable, Figures, Raw SpreadsheetHow data was acquiredOnline questionnaires + Website Analytics (WordPress)Data formatRaw and TabulatedExperimental factorsNo pre-treatment of data.Experimental featuresRandomization to text-only or multimedia e-health portal. Pre-, post-, 6+months post-intervention questionnaires.Data source locationAlberta, Canada (Primarily Edmonton, 53.5444°N, 113.4909°W)Data accessibilityDataset published on Mendeley Data: <https://data.mendeley.com/datasets/g223h3p8gy/1>Related research articles•Sutton R, Wierstra K, Bal J, et al. Pregnancy-related Beliefs and Concerns of Inflammatory Bowel Disease Patients are Modified After Accessing e-Health Portal. *Patient Education and Counceling.* 2019; (in press) [@bib1].•Wierstra K, Sutton R, Bal J, et al. Innovative Online Educational Portal Improves Disease-Specific Reproductive Knowledge Among Patients With Inflammatory Bowel Disease. *Inflamm Bowel Dis*. 2018;24(12):2483--2493. [doi:10.1093/ibd/izy1612](http://MEP_L_bib2){#ir0005}.

**Value of the data**•CCPKnow, MARS-5, and BMQ are validated questionnaires, and so this data provides a benchmark for comparison of patient populations from other centers, or contrast to populations from different demographics.•The data is extensive, containing disease history and patient demographics, information on user׳s technology preferences, methods of learning, and more.•These data can be utilized by researchers with interest in preconception and pregnancy in inflammatory bowel disease patient populations, combined with others' datasets, and analyzed for further insights.

1. Data {#s0005}
=======

The data collected at baseline includes demographics, DOB (converted to birth year to protect PII), highest level of education, employment, income, family history, languages, marital status, and extensive reproductive history including children, current pregnancy, pregnancy outcomes and health, future and current family plans. Inflammatory Bowel Disease history was also collected including family history of IBD, diagnosis, year diagnosed, previous and current medications, specialist access, discussion of reproductive topics in IBD, and sources of pregnancy in IBD information accessed. All of this data is included in [Appendix A](#s0040){ref-type="sec"}.

Standardized, validated questionnaires on knowledge ('CCPKnow'), reproductive concerns, beliefs about medications ('BMQ'), and medication adherence ('MARS-5') were also collected at pre-intervention, post-intervention, and 6+ months later. They are detailed below and included in [Appendix B](#s0040){ref-type="sec"}.1.*Patient reproductive concerns:* Six IBD-specific reproductive concern questions were asked (adapted from Marri et al.) [@bib3], [@bib4]. Participants responded 'yes' or 'no' to each statement.2.*MARS-5:* Self-reported adherence assessment utilizing a 5 statement questionnaire evaluating non-adherent medication taking behaviors [@bib5]. Each statement is scored on a 5-point Likert scale, ranging from 1 = always to 5 = never.3.*BMQ IBD S18:* The validated BMQ questionnaire, a version specific to IBD, was used to measure beliefs that influenced adherence to medications. Questions from the BMQ are classified as "specific"(personal beliefs), further subdivided into *necessity* and *concerns* scales [@bib6]. Participants ranked statements from each scale on a Likert spectrum (1 = strongly disagree, 5 = strongly agree). This particular version of the BMQ included 8 *necessity* statements and 9 *concerns* statements.4.*CCPKnow*: 17 item validated score used to measure IBD-specific reproductive knowledge [@bib7]. Correct answers to the questions (5 options each question) are usually summed to form a total score, and typically categorized into levels as follows;i.poor (0--7),ii.adequate (8--10)iii.good (11--13)iv.very good (14--17)

Feedback questions were asked regarding the intervention itself at post-intervention and 6 months later. The questions are included in [Appendix C](#s0040){ref-type="sec"}. Finally, analytics data on the usage and access time for specific pages and users was pulled from the portal, and is included in the raw datasets.

2. Experimental design, materials, and methods {#s0010}
==============================================

2.1. Design {#s0015}
-----------

A prospective randomized intervention study was conducted. Patients were invited to access an online e-health portal for reproductive health information in the context of inflammatory bowel disease. Recruitment methods have been described [@bib1], [@bib2]. Upon enrollment, patients completed the pre-intervention questionnaire (Appendices A and B), and were randomized (1:1) to receive access to either a text-only version of the portal content, or a multimedia version containing the same text content supplemented by videos, animated diagrams, slideshow, and self-testing quizzes. Patients were given 60 day access to the portal׳s content, before completing the post-intervention questionnaire ([Appendices B](#s0040){ref-type="sec"} and [C](#s0040){ref-type="sec"}). Six months later they completed the same questionnaires again ([Appendices B](#s0040){ref-type="sec"} and [C](#s0040){ref-type="sec"}).

2.2. Educational content {#s0020}
------------------------

The portal׳s education content (the 'intervention') was drafted by expert systematic literature review on topics previously found to be of interest to this patient population [@bib4]. Literature up to May 2014 was included. The content was aggregated into five modules:1.I have IBD, can I become pregnant?(<http://pregnancy.ibdclinic.ca/information/ibd-can-i-get-pregnant/>)2.I have IBD, will my child have IBD?(<http://pregnancy.ibdclinic.ca/information/will-my-child-have-ibd/>)3.I have IBD, could surgery affect my ability to become pregnant?(<http://pregnancy.ibdclinic.ca/information/ibd-surgery-affect-ability-become-pregnant/>)4.I have IBD, how does IBD affect pregnancy?(<http://pregnancy.ibdclinic.ca/information/how-does-ibd-affect-pregnancy/>)5.I have IBD, how does IBD affect delivery, postpartum, and breastfeeding?(<http://pregnancy.ibdclinic.ca/information/ibd-affect-delivery-postpartum-breastfeeding/>)?

*\*\*Please note that the content at the above links may have been updated since being used in the described study*.

2.3. Setting, participant characteristics {#s0025}
-----------------------------------------

Described previously, participants were 18--45 year old male and female IBD patients known to the IBD Clinic (University of Alberta Hospital, Edmonton, AB, Canada). The IBD Clinic serves patients from all over Alberta, and from surrounding provinces. The demographics have been tabulated for participants completing each of the three study time points ([Table 1](#t0005){ref-type="table"}).Table 1Demographics and medical information for participants at three study time points, pre-intervention, post-intervention, and 6+ months post-intervention.Table 1**CategoryPre-intervention CompletersPost-intervention Completers6-month study completers(n = 101)(n = 78)(n = 37)No. (% of total)No. (% of total)No. (% of total)**Age at prestudy, y 18--2424 (23.8)15 (19.2)7 (18.9) 25--2932 (31.7)29 (37.2)11 (29.7) 30--3428 (27.7)21 (26.9)12 (32.4) 35--3912 (11.9)10 (12.8)5 (13.5) 40--455 (5.0)3 (3.8)2 (5.4)  Sex Male18 (17.8)15 (19.2)7 (18.9) Female83 (82.2)63 (80.8)30 (81.1)  Marital status Single, never married33 (32.7)22 (28.2)14 (37.8) Divorced3 (3.0)3 (3.8)0 (0) Partnered65 (64.4)53 (67.9)23 (62.2)  1st language English92 (91.1)71 (91.0)32 (86.5)  Income (n = 77) Less than \$20, 00011 (11.2)8 (10.4)5 (13.5) \$20,000 to \$39,9996 (6.1)3 (3.9)1 (2.7) \$40,000 to \$69,99925 (25.5)23 (29.9)11 (29.7) \$70,000 to \$99,99953 (54.1)41 (53.2)20 (54.1) \$100,000 or more3 (3.1)2 (2.6)0 (0)  Education Grade 1210 (9.9)9 (11.5)4 (10.8) Some postsecondary22 (21.8)15 (19.2)4 (10.8) Bachelor׳s degree33 (32.7)28 (35.9)17 (45.9) Graduate degree21 (20.8)14 (17.9)9 (24.3) Technical/trade school degree15 (14.9)12 (15.4)3 (8.1)  Employment Unemployed9 (8.9)8 (10.3)4 (10.8) Part-time22 (21.8)15 (19.2)11 (29.7) Full-time63 (62.4)49 (62.8)20 (54.1) Stay-at-home mom7 (6.9)6 (7.7)2 (5.4)  Type of IBD Crohn׳s disease69 (68.3)54 (69.2)25 (67.6) Ulcerative colitis29 (28.7)21 (26.9)10 (27) Indeterminate3 (3.0)3 (3.8)2 (5.4)  Reproductive history Have biological children26 (25.7)19 (24.4)8 (21.6) Currently pregnant11 (10.9)5 (6.4)1 (2.7) Ever been pregnant27 (26.7)19 (24.4)9 (24.3)  Medication history Sulfasalazine12 (11.9)10 (12.8)6 (16.2) Mesalamine/5-ASA83 (82.2)67 (85.9)31 (83.8) Budesonide20 (19.8)17 (21.8)8 (21.6) Steroids82 (81.2)63 (80.8)31 (83.8) Methotrexate15 (14.9)12 (15.4)9 (24.3) Azathioprine/mercaptopurine72 (71.3)55 (70.5)27 (73) Anti-TNF/biologics54 (53.5)42 (53.8)22 (59.5) Antibiotics50 (49.5)38 (48.7)18 (48.6) Study medications10 (9.9)8 (10.3)4 (10.8)  Saw IBD specialist in outpatient gastroenterology clinic in the past year Yes84 (84.0)67 (85.9)33 (89.2) No16 (16.0)11 (14.1)4 (10.8)  Hospitalized for IBD in the past year Yes22 (22.)16 (20.5)4 (10.8) No78 (78.0)62 (79.5)33 (89.2)  Discussed pregnancy in IBD topics with: Gastroenterologist46 (45.5)36 (46.2)19 (51.4) General medicine specialist2 (2.0)2 (2.6)0 (0) Gynecologist/obstetrician17 (16.8)12 (15.4)7 (18.9) Family physician22 (21.8)18 (23.1)7 (18.9) IBD nurse16 (15.8)11 (14.1)4 (10.8) Pharmacist1 (1.0)1 (1.3)0 (0.0) Family and friends36 (35.6)29 (37.2)12 (35.1) Support groups2 (2.0)2 (2.6)1 (2.7)  Obtained information regarding pregnancy in IBD from: Internet52 (51.5)42 (53.8)22 (59.5) Pamphlets and brochures18 (17.8)14 (17.9)7 (18.9) Books6 (5.9)4 (5.1)1 (2.7)  Baseline CCPKnow level Poor (0--7)49 (48.5)37 (47.4)16 (43.2) Adequate (8--10)27 (26.7)22 (28.2)9 (24.3) Good (11--13)15 (14.9)13 (16.7)8 (21.6) Very good (14--17)10 (9.9)6 (7.7)4 (10.8)  Baseline CCPKnow**---**dichotomized Poor (0--7)49 (49.5)37 (47.4)16 (43.2) Adequate+ (\>7)52 (51.5)41 (52.6)21 (56.8)

Transparency document. Supplementary material {#s0040}
=============================================

Transparency document

Pixel Designs and Pulp Studios were contracted for website development and image design. The Canadian Digestive Health Foundation and Crohn׳s and Colitis Canada helped recruit subjects. Funding was provided by Alberta Innovates Health Solutions Knowledge-to-Action Grant and MacEwan University Undergraduate Student Research Initiative (USRI). Thank-you to research students, physicians, IBD nurses at the University of Alberta IBD Clinic, Division of Gastroenterology, and the Center of Excellence for Gastrointestinal Inflammation and Immunity Research (CEGIIR).

Ethics approval {#s0030}
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The study, including data collection procedures, was approved by the University of Alberta Health Research Ethics Board (Pro00047498).

Transparency document associated with this article can be found in the online version at <https://doi.org/10.1016/j.dib.2018.12.085>.
